178 related articles for article (PubMed ID: 22564737)
1. Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.
Patel D; Chaudhary J
Biochem Biophys Res Commun; 2012 May; 422(1):146-51. PubMed ID: 22564737
[TBL] [Abstract][Full Text] [Related]
2. Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.
Carey JP; Knowell AE; Chinaranagari S; Chaudhary J
Anticancer Res; 2013 Oct; 33(10):4271-8. PubMed ID: 24122992
[TBL] [Abstract][Full Text] [Related]
3. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.
Asirvatham AJ; Carey JP; Chaudhary J
Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499
[TBL] [Abstract][Full Text] [Related]
4. Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.
Patel D; Chinaranagari S; Chaudhary J
Am J Cancer Res; 2015; 5(11):3407-21. PubMed ID: 26807321
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
Sharma P; Chinaranagari S; Chaudhary J
Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
[TBL] [Abstract][Full Text] [Related]
8. Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.
Sharma P; Patel D; Chaudhary J
Cancer Med; 2012 Oct; 1(2):187-97. PubMed ID: 23342268
[TBL] [Abstract][Full Text] [Related]
9. Basic helix-loop-helix transcription factor DEC2 functions as an anti-apoptotic factor during paclitaxel-induced apoptosis in human prostate cancer cells.
Liu Q; Wu Y; Yoshizawa T; Yan X; Morohashi S; Seino H; Kato Y; Kijima H
Int J Mol Med; 2016 Dec; 38(6):1727-1733. PubMed ID: 27840924
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor 3 promotes migration and invasion potential and maintains cancer stemness by activating ID1 expression in esophageal squamous cell carcinoma.
Li ZX; Sun MC; Fang K; Zhao ZY; Leng ZY; Zhang ZH; Xu AP; Chu Y; Zhang L; Lian J; Chen T; Xu MD
Cancer Biol Ther; 2023 Dec; 24(1):2246206. PubMed ID: 37607071
[TBL] [Abstract][Full Text] [Related]
11. The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.
Kardava L; Yang Q; St Leger A; Foon KA; Lentzsch S; Vallejo AN; Milcarek C; Borghesi L
Int Immunol; 2011 Jun; 23(6):375-84. PubMed ID: 21551245
[TBL] [Abstract][Full Text] [Related]
12. E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.
López-Menéndez C; Vázquez-Naharro A; Santos V; Dubus P; Santamaría PG; Martínez-Ramírez Á; Portillo F; Moreno-Bueno G; Faraldo MM; Cano A
Cancer Res; 2021 Sep; 81(17):4529-4544. PubMed ID: 34145034
[TBL] [Abstract][Full Text] [Related]
13. E2A/HEB and Id3 proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression.
Ko M; Ahn J; Lee C; Chung H; Jeon SH; Chung HY; Seong RH
J Biol Chem; 2004 May; 279(21):21916-23. PubMed ID: 15016815
[TBL] [Abstract][Full Text] [Related]
14. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
16. Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer Cells.
Schnepp PM; Shelley G; Dai J; Wakim N; Jiang H; Mizokami A; Keller ET
Mol Cancer Res; 2020 Sep; 18(9):1290-1301. PubMed ID: 32513898
[TBL] [Abstract][Full Text] [Related]
17. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
18. The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells.
Kim W; Kook S; Kim DJ; Teodorof C; Song WK
J Biol Chem; 2004 Feb; 279(9):8333-42. PubMed ID: 14660614
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor E2A drives neural differentiation in pluripotent cells.
Rao C; Malaguti M; Mason JO; Lowell S
Development; 2020 Jun; 147(12):. PubMed ID: 32487737
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the bHLH transcription factor E2A in epithelial cells by interaction with the Na/K-ATPase beta1 subunit.
Plotkin M; Pelger L
Arch Biochem Biophys; 2008 Dec; 480(1):68-74. PubMed ID: 18727914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
